IMMUNOMIC THERAPEUTICS
Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines for the treatment of allergy and other human health targets. The company was founded in 2005 and is based in Lancaster, Pennsylvania.
IMMUNOMIC THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2005-01-01
Address:
Lancaster, Pennsylvania, United States
Country:
United States
Website Url:
http://www.immunomix.com
Total Employee:
11+
Status:
Active
Contact:
717-327-1919
Email Addresses:
[email protected]
Total Funding:
75.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Employees Featured
Founder
Investors List
HLB Co
HLB Co investment in Corporate Round - Immunomic Therapeutics
Keiretsu Forum Northwest
Keiretsu Forum Northwest investment in Venture Round - Immunomic Therapeutics
Mid Atlantic Bio Angels
Mid Atlantic Bio Angels investment in Venture Round - Immunomic Therapeutics
Brainchild Holdings
Brainchild Holdings investment in Venture Round - Immunomic Therapeutics
Life Sciences Greenhouse of Pennsylvania
Life Sciences Greenhouse of Pennsylvania investment in Venture Round - Immunomic Therapeutics
Minority Angel Investor Network
Minority Angel Investor Network investment in Venture Round - Immunomic Therapeutics
Key Employee Changes
Official Site Inspections
http://www.immunomix.com Semrush global rank: 3.63 M Semrush visits lastest month: 3.92 K
- Host name: 172.67.164.220
- IP address: 172.67.164.220
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Immunomic Therapeutics"
Overview, News & Similar companies - ZoomInfo.com
Aug 24, 2023 View Immunomic Therapeutics (www.immunomix.com) location in Maryland, United States , revenue, industry and description. Find related and similar companies as well … See details»
Culture & Beliefs - Immunomic Therapeutics
Immunomic Therapeutics, Inc. (ITI) is a privately-held, clinical-stage biotechnology company pioneering the development of vaccines through its proprietary technology platform, UNiversal … See details»
Partnerships - Immunomic Therapeutics
Immunomic Therapeutics’ domain expertise is in vaccine design, development, manufacturing and testing. In collaborating with Immunomic, expect an … See details»
Pipeline - Immunomic Therapeutics
Stemming from our UNITE® Platform, Immunomic Therapeutics has developed a robust pipeline focused on immunotherapeutics with an emphasis in treating and preventing many oncology … See details»
immunomix.com
Immunomix.com See details»
Immunomic Therapeutics, Inc
Immunomic Therapeutics is a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms. See details»
Careers - Immunomic Therapeutics
The Immunomic Therapeutics, Inc. team includes specialists in the areas of science, process development, engineering, production, marketing, finance, human resources, quality and … See details»
Immunomic Therapeutics, Inc. - Drug pipelines, Patents, Clinical …
Oct 3, 2023 Explore Immunomic Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 8 clinical trials, 21 news, and 7 literature, Disease Domain ... See details»
Immunomic Therapeutics - Crunchbase Company …
Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines. See details»
ImmunyX - A New Paradigm for Immune Modulation
ImmunyX is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. See details»
Immunomic Therapeutics, Inc. - LinkedIn
Immunomic Therapeutics, Inc. | 3,220 followers on LinkedIn. A privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms | … See details»
Team - Immunomic Therapeutics
Immunomic Therapeutics, Inc. is committed to building, developing and retaining a world-class team. We are looking for passionate individuals who want to create leading edge technology, … See details»
Immunomic Therapeutics - VentureRadar
"Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company headquartered in Hershey, PA with lab facilities in Rockville, MD. ITI is developing next … See details»
Immunofyx
ImmunoFyx is developing novel immuno-therapeutics to reduce the growth, angiogenesis, and metastasis of solid tumors. We specifically target and inhibit a highly expressed cell surface … See details»
Working At Immunomic Therapeutics: Company Overview and …
Mar 14, 2024 Find out what it's like to work at Immunomic Therapeutics. See what kind of people work at Immunomic Therapeutics, career paths working at Immunomic Therapeutics, company … See details»
Immunomic Therapeutics (USA) Funding: $78.4M
Jun 25, 2025 Website: https://www.immunomix.com Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based … See details»
Immunomix : Immunomic Therapeutics, Inc.
Registrant Organization: Immunomic Therapeutics Registrant Street: 15010 Broschart Rd. Ste. 250, Registrant City: Rockville Registrant State/Province: MD Registrant Postal Code: 20850 … See details»
Immunomic Therapeutics - News & Analysis - Crunchbase
Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines. See details»
News | Astellas Pharma Inc.
Oct 9, 2015 For information about Immunomic Therapeutics and LAMP technology, visit www.immunomix.com. About Astellas Astellas Pharma Inc., based in Tokyo, Japan, is a … See details»
Immunomic Therapeutics - Financial Details - Crunchbase
Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines. See details»